MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,538 Cr | ₹848 Cr | ₹576 Cr | ₹388 Cr | ₹331 Cr |
What is the latest Sundry Debtors ratio of MANKIND PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹1,538 Cr |
| Mar2024 | ₹848 Cr |
| Mar2023 | ₹576 Cr |
| Mar2022 | ₹388 Cr |
| Mar2021 | ₹331 Cr |
How is Sundry Debtors of MANKIND PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,538 Cr | 81.35 | |
| Mar2024 | ₹848 Cr | 47.16 | |
| Mar2023 | ₹576 Cr | 48.50 | |
| Mar2022 | ₹388 Cr | 17.41 | |
| Mar2021 | ₹331 Cr | - | |
Compare Sundry Debtors of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹87,645.7 Cr | 2.1% | -0.7% | -9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.1% |
-0.7% |
-9.1% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses